首页> 外文期刊>Cell death and differentiation >Cyclophilin A release as a biomarker of necrotic cell death.
【24h】

Cyclophilin A release as a biomarker of necrotic cell death.

机译:亲环蛋白A释放作为坏死细胞死亡的生物标记。

获取原文
获取原文并翻译 | 示例
           

摘要

Necroptosis is a form of programmed necrotic cell death mediated by the activity of receptor-interacting protein 1 (RIP1) kinase. This type of cell death is caspase-indepen-dent, is marked by early membrane permeabilization and does not exhibit any other hallmarks of apoptotic cell death such as phosphatidylserine extemalization or DNA strand breaks. Thus, the markers available to characterize apoptotic cell death cannot be used to analyze necroptosis. Only one marker of necrosis has been identified, and that is the release of the chromatin protein high-mobility group B1 (HMGB1).2 However, we have found the release of HMGB1 to occur at a late stage of death. In this study, we have found that cyclophilin A (CypA), a cytosolic peptidyl-prolyl cis-trans isomerase, is released early in necroptosis. We propose that the release of CypA may be used as a biomarker for necroptosis and other cell death processes when the integrity of the plasma membrane is compromised.
机译:坏死性坏死病是通过受体相互作用蛋白1(RIP1)激酶的活性介导的程序性坏死性细胞死亡的一种形式。这种类型的细胞死亡是半胱天冬酶依赖性的,以早期的膜通透性为特征,并且没有表现出任何其他凋亡性细胞死亡的标志,例如磷脂酰丝氨酸的过度剥夺或DNA链断裂。因此,可用于表征凋亡性细胞死亡的标记不能用于分析坏死病。仅鉴定出一种坏死标志物,即染色质蛋白高迁移率组B1(HMGB1)的释放。2但是,我们发现HMGB1的释放发生在死亡后期。在这项研究中,我们发现亲环蛋白A(CypA),一种胞质肽基脯氨酰顺反异构酶,在坏死病早期释放。我们建议,当质膜的完整性受到损害时,CypA的释放可用作尸检和其他细胞死亡过程的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号